Canobbio L - Search Results

1

Disparity in the "time to patient access" to new anti-cancer drugs in Italian regions. Results of a survey conducted by the Italian Society of Medical Oncology (AIOM).

Gori S, Di Maio M, Pinto C, Alabiso O, Baldini E, Barbato E, Beretta GD, Bravi S, Caffo O, Canobbio L, Carrozza F, Cinieri S, Cruciani G, Dinota A, Gebbia V, Giustini L, Graiff C, Molino A, Muggiano A, Pandoli G, Puglisi F, Tagliaferri P, Tomao S, Venturini M; AIOM Working Group "Interactions with Regional Sections" (2009-2011). Gori S, et al. Among authors: canobbio l. Tumori. 2011 Jul-Aug;97(4):442-8. doi: 10.1177/030089161109700405. Tumori. 2011. PMID: 21989431

2

Impact of use of oral anticancer drugs on activity of Italian oncology practices: results of a survey conducted by the Italian Society of Medical Oncology (AIOM).

Gori S, Di Maio M, Pinto C, Alabiso O, Baldini E, Barbato E, Beretta GD, Bravi S, Caffo O, Canobbio L, Carrozza F, Cinieri S, Cruciani G, Dinota A, Gebbia V, Giustini L, Graiff C, Molino A, Muggiano A, Pandoli G, Puglisi F, Tagliaferri P, Tomao S, Lunardi G, Venturini M; AIOM Working Group “Interaction with Regional Sections” (2009-2011). Gori S, et al. Among authors: canobbio l. Tumori. 2013 Jan-Feb;99(1):35-8. doi: 10.1177/030089161309900106. Tumori. 2013. PMID: 23548997

3

Interleukin-2, interferon-alpha and interleukin-2 plus interferon-alpha in renal cell carcinoma. A randomized phase II trial.

Boccardo F, Rubagotti A, Canobbio L, Galligioni E, Sorio R, Lucenti A, Cognetti F, Ruggeri E, Landonio G, Baiocchi C, Besana C, Citterio G, De Rosa M, Calabresi F. Boccardo F, et al. Among authors: canobbio l. Tumori. 1998 Sep-Oct;84(5):534-9. doi: 10.1177/030089169808400505. Tumori. 1998. PMID: 9862512 Clinical Trial.

4

Randomised comparison of weekly bolus 5-fluorouracil with or without leucovorin in metastatic colorectal carcinoma.

Nobile MT, Rosso R, Sertoli MR, Rubagotti A, Vidili MG, Guglielmi A, Venturini M, Canobbio L, Fassio T, Gallo L, et al. Nobile MT, et al. Among authors: canobbio l. Eur J Cancer. 1992;28A(11):1823-7. doi: 10.1016/0959-8049(92)90013-r. Eur J Cancer. 1992. PMID: 1389519 Clinical Trial.

5

Prognostic factors for survival in patients with advanced renal cell carcinoma treated with interleukin-2 and interferon-alpha.

Canobbio L, Rubagotti A, Miglietta L, Cannata D, Curotto A, Amoroso D, Boccardo F. Canobbio L, et al. J Cancer Res Clin Oncol. 1995;121(12):753-6. doi: 10.1007/BF01213322. J Cancer Res Clin Oncol. 1995. PMID: 7499447 Clinical Trial.

6

Medical treatment of advanced renal cell carcinoma: present options and future directions.

Canobbio L, Miglietta L, Boccardo F. Canobbio L, et al. Cancer Treat Rev. 1996 Mar;22(2):85-104. doi: 10.1016/s0305-7372(96)90029-8. Cancer Treat Rev. 1996. PMID: 8665566 Review.

7

Phase II study of tamoxifen and high-dose retinyl acetate in patients with advanced breast cancer.

Boccardo F, Canobbio L, Resasco M, Decensi AU, Pastorino G, Brema F. Boccardo F, et al. Among authors: canobbio l. J Cancer Res Clin Oncol. 1990;116(5):503-6. doi: 10.1007/BF01613002. J Cancer Res Clin Oncol. 1990. PMID: 2229142 Clinical Trial.

8

Carboplatin, methotrexate, and vinblastine in the treatment of patients with advanced urothelial cancer. A phase II trial.

Boccardo F, Pace M, Guarneri D, Canobbio L, Curotto A, Martorana G. Boccardo F, et al. Among authors: canobbio l. Cancer. 1994 Apr 1;73(7):1932-6. doi: 10.1002/1097-0142(19940401)73:7<1932::aid-cncr2820730726>3.0.co;2-y. Cancer. 1994. PMID: 8137220 Clinical Trial.

9

Prophylaxis of superficial bladder cancer with mitomycin or interferon alfa-2b: results of a multicentric Italian study.

Boccardo F, Cannata D, Rubagotti A, Guarneri D, Decensi A, Canobbio L, Curotto A, Martorana G, Pegoraro C, Selvaggi F, et al. Boccardo F, et al. Among authors: canobbio l. J Clin Oncol. 1994 Jan;12(1):7-13. doi: 10.1200/JCO.1994.12.1.7. J Clin Oncol. 1994. PMID: 8270987 Clinical Trial.

10

Combination therapy with subcutaneous interleukin-2 and interferon-alpha in advanced renal cancer patients with poor prognostic factors.

Canobbio L, Curotto A, Cannata D, Miglietta L, Lavarello A, Giglio C, Franchini R, Cussotto M, Boccardo F. Canobbio L, et al. Anticancer Res. 1996 Jan-Feb;16(1):541-4. Anticancer Res. 1996. PMID: 8615668 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

56 results

Search Page